How should I evaluate and manage a patient with elevated parathyroid hormone and elevated thyroid hormones?

Evaluation and Management of Elevated PTH and Thyroid Hormones

When you encounter a patient with both elevated PTH and elevated thyroid hormones, first confirm true primary hyperparathyroidism by measuring serum calcium, 25(OH) vitamin D, 24-hour urine calcium, and fractional excretion of calcium (FeCa), while simultaneously establishing the etiology of thyrotoxicosis through TSH, free T4, and thyroid-stimulating immunoglobulin (TSI/TRAb) testing.

Initial Diagnostic Workup

For the Elevated PTH Component

The diagnosis of primary hyperparathyroidism (PHPT) requires a systematic approach 1:

• Measure serum calcium - Look for hypercalcemia as the hallmark finding
• Check 25(OH) vitamin D levels - Vitamin D deficiency/insufficiency causes secondary hyperparathyroidism and must be corrected for at least 6 months before diagnosing normocalcemic PHPT 1
• Calculate FeCa (fractional excretion of calcium) - A value >2% indicates PHPT and helps distinguish it from familial hypocalciuric hypercalcemia 1
• Obtain 24-hour urine calcium - Hypercalciuria (>7.5 mmol/24h in men, >6.25 mmol/24h in women) is typical 1
• Consider ionized calcium - Particularly useful when total calcium is borderline or only moderately elevated 1

The typical form of PHPT combines hypercalcemia, elevated PTH, and elevated FeCa 1. However, be aware that PTH may appear "normal" but is inappropriately elevated for the degree of hypercalcemia 1.

For the Elevated Thyroid Hormones Component

Confirm thyrotoxicosis and determine etiology 2:

• Measure TSH and free T4/T3 - Suppressed TSH with elevated thyroid hormones confirms thyrotoxicosis
• Obtain TRAb or TSI - Second-generation assays have 99% specificity and 95% sensitivity for Graves' disease 2
• Consider radioactive iodine uptake scan if antibodies are negative to distinguish between Graves' disease, toxic nodular goiter, or thyroiditis

Critical Clinical Consideration

This combination is exceedingly rare 3. The concurrent presentation of primary hyperthyroidism (particularly Graves' disease) and PHPT requires heightened clinical suspicion. Hypercalcemia in a hyperthyroid patient should always prompt evaluation for PHPT 3.

Exclude Secondary Causes of Elevated PTH

Before confirming PHPT, systematically rule out 1:

• Vitamin D deficiency - Cannot cause hypercalcemia but commonly causes secondary hyperparathyroidism
• Renal insufficiency - Check creatinine and eGFR
• Inadequate calcium intake - Use validated questionnaires
• Malabsorption - History of bariatric surgery or chronic diarrhea

Management Algorithm

Step 1: Symptomatic Management of Thyrotoxicosis

Initiate beta-blockade immediately for symptomatic patients 2:

• Mandatory for elderly patients, those with resting heart rate >90 bpm, or cardiovascular disease 2
• Consider for all symptomatic thyrotoxic patients 2
• Use propranolol, atenolol, or metoprolol to control heart rate, blood pressure, tremor, and irritability 2
• Calcium channel blockers (verapamil or diltiazem) are alternatives if beta-blockers are contraindicated 2

Step 2: Determine Definitive Treatment Strategy

Surgery is the only curative treatment for PHPT and should be coordinated with thyroid management through a multidisciplinary team approach 3, 4.

For PHPT Management:

Parathyroidectomy is indicated for all symptomatic patients and should be considered for most asymptomatic patients 4:

• Obtain preoperative imaging: cervical ultrasound (to assess thyroid pathology) and functional imaging (Sestamibi or F-choline PET) 5
• Measure bone density via DEXA scan 4
• Patients with nonlocalizing imaging remain surgical candidates 4
• High-volume surgeons achieve better outcomes 4

For Hyperthyroidism Management:

For Graves' disease, three treatment options exist 2:

1. Radioactive iodine (RAI) - Most common in US
2. Antithyroid drugs (ATDs) - Preferred in Europe/Japan
3. Thyroidectomy - Surgical option

Step 3: Coordinate Surgical Approach When Both Conditions Require Surgery

When both PHPT and hyperthyroidism require surgical management, a combined approach should be planned by a multidisciplinary team 3:

• Preoperative preparation decisions include:

  • Whether to use iodine preparation (Lugol's solution) before thyroid surgery
  • Whether to normalize thyroid function with ATDs before surgery
  • Extent of parathyroidectomy if parathyroid hyperplasia is present

• The surgical plan must balance 3:

  • Risk of postoperative thyroid storm
  • Risk of PHPT recurrence
  • Risk of permanent hypoparathyroidism

Both focused minimally invasive parathyroidectomy and bilateral exploration achieve high cure rates for PHPT 4. For minimally invasive approaches, intraoperative PTH monitoring is recommended 4.

Key Pitfalls to Avoid

1. Do not attribute hypercalcemia to thyrotoxicosis alone - While thyrotoxicosis can cause mild hypercalcemia through increased bone turnover, concurrent PHPT must be excluded 3

2. Do not diagnose normocalcemic PHPT without correcting vitamin D deficiency first - Wait at least 6 months after vitamin D repletion 1

3. Do not perform preoperative parathyroid biopsy - This should be avoided 4

4. Do not overlook familial syndromes - Up to 10% of PHPT cases are hereditary; consider genetic testing in young patients or those with family history 6

5. Assess for devascularized parathyroid tissue during surgery - This should be autotransplanted to prevent permanent hypoparathyroidism 4

Postoperative Management

• Monitor for hematoma, hypocalcemia, and symptoms of hypocalcemia 4
• Calcium supplementation may be indicated postoperatively 4
• Assess for cure at >6 months with eucalcemia 4
• Monitor for thyroid storm if thyroidectomy performed - This risk is mitigated by proper preoperative preparation and MDT planning 3